Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 1;24(2):103-106.

What are the treatment options for beta-thalassemia patients with osteoporosis? A Cochrane Review summary with commentary

Sina Arman  1
Affiliations

What are the treatment options for beta-thalassemia patients with osteoporosis? A Cochrane Review summary with commentary

Sina Arman. J Musculoskelet Neuronal Interact. .
No abstract available

Keywords: Βeta-thalassemia; Βisphosphonates; Οsteoporosis; Τreatment.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflicts of interest.

Similar articles

See all similar articles

References

    1. Bhardwaj A, Swe KM, Sinha NK, Osunkwo I. Treatment for osteoporosis in people with ß-thalassaemia . Cochrane Database Syst Rev. 2023;5:CD010429. doi: 10.1002/14651858.CD010429.pub3. - DOI - DOI - PMC - PubMed
    1. Gagliardi I, Celico M, Gamberini MR, Pontrelli M, Fortini M, Carnevale A, et al. Efficacy and safety of teriparatide in beta-thalassemia major Associated osteoporosis:a real-life experience. Calcif Tissue Int. 2022;111(1):56–65. - PMC - PubMed
    1. Farmakis D, Porter J, Taher A, Cappellini MD, Angastiniotis M, Eleftheriou A. 2021 Thalassaemia International Federation Guidelines for the management of transfusion-dependent thalassemia. Hemasphere. 2022;6(8):e732. - PMC - PubMed
    1. Taher AT, Musallam KM, Cappellini MD. β-Thalassemias. N Engl J Med. 2021;384(8):727–743. - PubMed
    1. Giusti A, Pinto V, Forni GL, Pilotto A. Management of beta-thalassemia-associated osteoporosis. Ann N Y Acad Sci. 2016;1368(1):73–81. - PubMed

MeSH terms

Substances